文献速递眼底病与葡萄膜炎

CoPP诱导HO-1过表达快速减轻光感受器变性

CoPP-Induced-Induced HO-1 Overexpression Alleviates Photoreceptor Degeneration With Rapid Dynamics: A Therapeutic Molecular Against Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

本研究在MNU诱导的视网膜色素变性小鼠模型中分析HO-1表达,并静脉注射CoPP进行干预。结果显示CoPP增强视网膜HO-1表达,改善视网膜反应性、保留视网膜结构、有效挽救视锥光感受器,并调节凋亡与氧化应激。CoPP可能成为治疗退行性视网膜病的潜在药物。

要点

  • CoPP静脉注射增强MNU小鼠视网膜HO-1表达。
  • CoPP改善MNU小鼠视网膜电图反应与行为学表现。
  • CoPP有效挽救视锥光感受器并减轻氧化应激与凋亡。

核心结论

  • CoPP减轻MNU诱导的小鼠光感受器变性并纠正视觉信号异常。
  • CoPP可能作为治疗退行性视网膜病的潜在药物。

研究设计与样本

  • 研究使用MNU给药小鼠作为化学诱导的视网膜色素变性模型。
  • 对MNU小鼠视网膜HO-1表达进行分析,并静脉注射CoPP后进行功能与形态学检查。

主要发现

  • HO-1参与MNU诱导的光感受器变性。
  • CoPP治疗增强MNU小鼠视网膜HO-1表达。
  • ERG和行为学测试显示CoPP改善MNU小鼠视网膜反应性。
  • 组织学与OCT显示CoPP治疗组视网膜结构较MNU+vehicle组更完整。
  • MEA记录显示CoPP减轻自发放电反应、增强光诱发放电反应并保留视觉信号通路基本构型。

关键数值与推荐

  • CoPP治疗有效挽救MNU小鼠视锥光感受器。
  • 机制研究提示CoPP通过调节凋亡级联和减轻退化视网膜氧化应激发挥治疗作用。

临床怎么用

  • CoPP在MNU小鼠中展示出对光感受器变性的治疗潜力,提示HO-1诱导可能为视网膜退行性疾病提供干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Retinitis pigmentosa (RP) causes progressive photoreceptor degeneration in the retina. The N-methyl-N-nitrosourea (MNU)-administered mouse is used as a chemically induced RP model with rapid progression rate. This study was designed to study heme oxygenase-1 (HO-1) expression in the MNU-administered mice, and to explore the therapeutic effects of cobalt protoporphyrin (CoPP). METHODS: The HO-1 expression in the retina of MNU-administered mice was analyzed. CoPP was injected intravenously into the MNU-administered mice. Subsequently, the CoPP-treated mice were subjected to functional and morphologic examinations. RESULTS: HO-1 was involved in the MNU-induced photoreceptor degeneration. CoPP treatment enhanced retinal HO-1 expression in the MNU-administered mice. Electroretinogram (ERG) examination and behavioral tests showed that CoPP treatment improved the retinal responsiveness of MNU-administered mice. Histologic analysis and optical coherence tomography (OCT) examination showed that retinal architecture of the CoPP-treated mice was more intact than that of the MNU+vehicle group. Cone photoreceptors in the MNU-administered mice were rescued efficiently by CoPP treatment. Furthermore, multielectrode array (MEA) recording showed that CoPP treatment mitigated the spontaneous firing response, enhanced the light-induced firing response, and preserved the basic configurations of visual signal pathway in the MNU-administered mice. Mechanism studies suggested that CoPP afforded these therapeutic effects by modulating the apoptosis cascades and alleviating the oxidative stress in degenerative retinas. CONCLUSIONS: CoPP alleviated photoreceptor degeneration and rectified the signaling abnormities in MNU-administered mice. CoPP may serve as a potential medication against degenerative retinopathy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Tao Y, Cai L, Zhou D, et al. CoPP-Induced-Induced HO-1 Overexpression Alleviates Photoreceptor Degeneration With Rapid Dynamics: A Therapeutic Molecular Against Retinopathy. Invest Ophthalmol Vis Sci. 2019. PMID: 31825462. doi:10.1167/iovs.19-26876

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。